Cerebrospinal fluid shunt-associated surgical site infection with three-month versus twelve-month surveillance periods in Canadian hospitals
- PMID: 35708283
- PMCID: PMC10262167
- DOI: 10.1017/ice.2022.119
Cerebrospinal fluid shunt-associated surgical site infection with three-month versus twelve-month surveillance periods in Canadian hospitals
Abstract
Cerebrospinal fluid shunt-associated surgical site infection surveillance for 3 months compared to 12 months after surgery captures 83% of cases with no significant differences in patient characteristics, surgery types, or pathogens. A shorter 3-month follow-up can reduce resource use and allow for more timely reporting of healthcare-associated infection rates for hospitals.
Conflict of interest statement
John Conly holds grants from the Canadian Institutes for Health Research on acute and primary care preparedness for COVID-19 in Alberta, Canada and was the primary local Investigator for a
Figures
References
-
- Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery 2010;66:284–289. - PubMed
-
- Paff M, Alexandru-Abrams D, Muhonen M, Loudon W. Ventriculoperitoneal shunt complications: a review. Interdiscip Neurosurg Adv Tech Case Manag 2018;13:66–70.
-
- Langley JM, Gravel D, Moore D, et al. Study of cerebrospinal fluid shunt–associated infections in the first year following placement, by the Canadian Nosocomial Infection Surveillance Program. Infect Control Hosp Epidemiol 2009;30:285–288. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
